| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |